市場調査レポート
商品コード
1390619
放射線治療市場:世界の産業動向、シェア、規模、成長、機会、2023-2028年予測Radiotherapy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
放射線治療市場:世界の産業動向、シェア、規模、成長、機会、2023-2028年予測 |
出版日: 2023年11月24日
発行: IMARC
ページ情報: 英文 147 Pages
納期: 2~3営業日
|
世界の放射線治療市場規模は2022年に65億米ドルに達しました。今後、IMARC Groupは、市場は2028年までに85億米ドルに達し、2022~2028年の成長率(CAGR)は4.57%になると予測しています。
放射線治療は、放射線療法としても知られ、がん細胞の成長を遅らせ、腫瘍を縮小させるために使用されます。X線、ガンマ線、電子線、陽子線などの高エネルギー粒子や波動を用いてがん細胞の遺伝物質を破壊します。手術や化学療法、免疫療法など、他のがん治療と組み合わせて効果を高めることができます。現在のところ、がんの種類、腫瘍の大きさや位置、病歴、年齢や病状に応じて患者に提供されています。
不健康な食事パターン、運動不足、大気汚染の深刻化、アルコールやタバコの消費量の増加などを背景に、がんの有病率が上昇していることは、市場の成長を強化する重要な要因の1つです。さらに、高齢者では細胞修復の傾向が弱くなるため、がんの発症リスクは加齢とともに劇的に上昇します。その結果、世界中で老年人口が増加していることも、成長を促す重要な要因となっています。これとは別に、効果的で低コスト、使いやすい放射線治療製品の市場開拓が市場成長を後押ししています。さらに、3Dコンフォーマル、強度変調、画像誘導などの最新の放射線治療技術は、健康な組織には低線量の放射線を、腫瘍には高線量の放射線を照射します。また、臓器アットリスク(OAR)温存を改善し、患者に身体的感覚を与えないです。このため、慢性疾患治療におけるさまざまな用途や場面での採用が増加しており、これが世界の放射線治療需要を刺激しています。さらに、新興経済諸国と先進経済諸国の両方でヘルスケア支出が増加していることから、市場は成長すると予測されています。
The global radiotherapy market size reached US$ 6.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 8.5 Billion by 2028, exhibiting a growth rate (CAGR) of 4.57% during 2022-2028.
Radiotherapy, also known as radiation therapy, is used to slow down the growth of cancer cells and shrink tumors. It destroys the genetic material of cancer cells using high-energy particles or waves, such as x-rays, gamma rays, electron beams, or protons. It can be combined with other cancer treatments, such as surgery, chemotherapy, and immunotherapy, to improve their effectiveness. At present, it is offered to patients depending on their cancer type, size and location of the tumor, medical history, and age and medical conditions.
The rising prevalence of cancer on account of unhealthy dietary patterns, lack of physical activities, growing air pollution, and the increasing number of alcohol and tobacco consumption represents one of the key factors strengthening the growth of the market. Moreover, the risk of developing cancer rises dramatically with age as the tendency for cellular repair is less effective in older individuals. As a result, the rising geriatric population across the globe is acting as another significant growth-inducing factor. Apart from this, the development of effective, low-cost, and easy-to-use radiotherapy products is bolstering the growth of the market growth. In addition, modern radiotherapy techniques, such as three-dimensional (3D) conformal, intensity-modulated, and image-guided, deliver a lower dose of radiation to healthy tissues while a higher dose to the tumor. They also improve organ-at-risk (OAR) sparing and provide no physical sensation to patients. This is increasing their adoption in multiple applications and settings in chronic disease treatment, which, in turn, is catalyzing the demand for radiotherapy around the world. Furthermore, the market is projected to experience growth on account of the rising healthcare expenditure in both emerging and developed economies.
IMARC Group provides an analysis of the key trends in each sub-segment of the global radiotherapy market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, application and end user.
External Beam Radiation Therapy
Intensity-Modulated Radiation Therapy (IMRT)
Image-Guided Radiation Therapy (IGRT)
Tomotherapy
Stereotactic Radiosurgery
Stereotactic Body Radiation Therapy
Proton Therapy
3D Conformal Radiotherapy (3D CRT)
Volumetric Modulated Arc Therapy (VMAT)
Internal Radiation Therapy/Brachytherapy
Systemic Radiation Therapy
Skin and Lip Cancer
Head and Neck Cancer
Breast Cancer
Prostate Cancer
Cervical Cancer
Lung Cancer
Others
Hospitals
Cancer Research Institutes
Ambulatory and Radiotherapy Centers
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Accuray Incorporated, Becton Dickinson and Company, Eckert & Ziegler, Elekta AB (publ), General Electric Company, Hitachi Ltd, Ion Beam Applications, Isoray Inc., Mevion Medical Systems Inc., Nordion Inc. (Sotera Health) and Siemens Healthineers AG (Siemens AG).